(Nanowerk News) Syringe-injectable biomaterials, medical devices and engineered tissues have attracted great attention as minimally-invasive implants for diagnosis, therapy and regenerative medicine.

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...

While there are many that are good for us, bacteria can be insidious little organisms, with some of them using tiny syringes to inject toxins into their host’s cells. Now, researchers from the Max ...

Syringe-injectable biomaterials, medical devices and engineered tissues have attracted great attention as minimally-invasive implants for diagnosis, therapy and regenerative medicine. Free-standing ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...

(MENAFN- GetNews) Mordor Intelligence has published a new report on sterile injectable drugs market offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction ...

A new intervention could save lives, recognizing that adolescents are at higher risk for fatal food-allergic reactions. Researchers from the Icahn School of Medicine at Mount Sinai have found that ...

SCHOTT has been expanding its manufacturing capacity for small size (1ml to 10 ml) SCHOTT TopPac® syringes in order ...

Skyrizi is used to treat autoimmune and inflammatory conditions like Crohn’s disease and plaque psoriasis. It is administered via intravenous injection by a healthcare professional or subcutaneous ...

The ultrathin films are able to be injected using minimally-invasive syringe needles and can be used as a platform to deliver molecular and cellular drugs. The use of shape-memory polymer also enables ...